Home
  Healthcare professionals Patients
     Go
Home
Products
Medical Information
Basics of Coagulation
Oral Anticoagulation
Prothrombin Time/International Normalized Ratio
Indications for PT/INR Monitoring
Benefits of Coagulation Self-Monitoring
Training Centres
Info Centre
Events
Contact
 

Medical Information

In this section, you will find detailed information on coagulation basics, most common medical conditions requiring long term oral anticoagulant therapy and the benefits of Coagulation Self-Testing for you and for your patient.

Our experience in Coagulation Monitoring dating back to 1993 can help you get a clearer overview about our CoaguChek product line. Please make sure to contact your local Roche Diagnostics representative for any further questions.

Basics of Coagulation
Blood coagulation plays a crucial role in haemostasis though it only occurs through the interaction of numerous factors. The human body, through a complex mechanism that causes blood to clot if a wound occurs, protects itself from excessive blood loss on one hand, and from excessive clotting on the other hand. more

Oral Anticoagulation
It is vital that the haemostatic and anti-haemostatic mechanisms are fully functional and in balance. Even a slight change in certain coagulation factors or inhibitors can lead to excessive blood coagulation and thus to thromboembolism. more

Prothrombin Time/International Normalised Ratio
Prothrombin time and International Normalised Ratio are the parameters used to follow up the success of oral anticoagulation therapy. Here you will find a short explanation of the different terms used in the field of anticoagulation monitoring. more

Indications for PT/INR Monitoring
The main indications for a patient to receive vitamin K antagonists (coumarin derivatives) and to monitor PT/INR values are the following: more

Benefits of Coagulation Self-Monitoring
The CoaguChek family of instruments helps both you and your patient to benefit from Coagulation Self-Testing. An increase in time within the therapeutic range produces a decrease in major potential complication rates. more

 
 

 
Last modified: 25 September 2006
 
  Further Links  
 
Basics of Coagulation
Bibliography
FAQ
 
© Roche Diagnostics Ltd. 2010 / Legal/Privacy Policy / Disclaimer
  This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.